| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,950,000 | 1,835,000 | 1,761,000 | 1,529,000 | | Cost of Revenue |
-
|
-
|
-
| 417,000 | | | Gross Profit |
-
| 1,835,000 | 1,761,000 | 1,112,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 355,000 | 2,064,000 | 1,068,000 | 948,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,210,000 | (125,000) | 286,000 | 395,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 286,000 | (104,000) | 407,000 | (231,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 385,000 | (104,000) | 407,000 | (231,000) | | Interest Expense | 45,000 | (219,000) | 273,000 | 410,000 | | Income Before Tax | 340,000 | 115,000 | 134,000 | (641,000) | | Income Tax Expense | 80,000 | 28,000 | 18,000 | (272,000) | | Minority Interest | 22,000 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 260,000 | 87,000 | 116,000 | (369,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 282,000 | 87,000 | 116,000 | (369,000) | | Preferred Stock And Other Adjustments | (22,000) | 8,000 | 14,000 |
-
| | | Net Income Applicable To Common Shares | $260,000 | $95,000 | $130,000 | ($369,000) |
|
0.20% Nasdaq 
0.14%
Income Statement
